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Lipoate-protein ligase A (LplA) catalyzes the formation of
lipoyl-AMP from lipoate and ATP and then transfers the lipoyl
moiety to a specific lysine residue on the acyltransferase subunit
of -ketoacid dehydrogenase complexes and on H-protein of the
glycine cleavage system. The lypoyllysine arm plays a pivotal role
in the complexes by shuttling the reaction intermediate and
reducing equivalents between the active sites of the components
of the complexes. We have determined the X-ray crystal struc-
tures of Escherichia coli LplA alone and in a complex with lipoic
acid at 2.4 and 2.9 Å resolution, respectively. The structure of
LplA consists of a large N-terminal domain and a small C-termi-
nal domain. The structure identifies the substrate binding
pocket at the interface between the two domains. Lipoic acid is
bound in a hydrophobic cavity in the N-terminal domain through
hydrophobic interactions and a weak hydrogen bond between
carboxyl group of lipoic acid and the Ser-72 or Arg-140 residue of
LplA. No large conformational change was observed in the main
chain structure upon the binding of lipoic acid.
Lipoic acid is a prosthetic group of acyltransferase (E2) subunit of
the pyruvate, -ketoglutarate, and branched-chain -ketoacid dehy-
drogenase complexes and of H-protein of the glycine cleavage sys-
tem (1–4). It attaches to a specific lysine residue on the proteins via
an amide linkage between the -amino group of the lysine residue
and the carboxyl group of lipoic acid. In the reaction sequence of the
complexes, the lypoyllysine arm shuttles the reaction intermediates
and reducing equivalents between the active sites of the components
of the complexes.
The attachment of lipoic acid to the proteins occurs by two-step
reactions inwhich a lipoyl-AMP intermediate is formed from lipoic acid
andATP, and pyrophosphate is released in the initial activation reaction
(Reaction 1).
Lipoate  ATP 3 lipoyl-AMP  PPi
REACTION 1
The lipoyl moiety of the intermediate is then transferred to apopro-
teins in the second transfer reaction, yielding the lipoylated protein and
AMP (Reaction 2).
Lipoyl-AMP apoprotein3 lipoylated proteinAMP
REACTION 2
Lipoate-protein ligase A (LplA)2 from Escherichia coli catalyzes the
above two reactions. LplA activates and transfers not only naturally
occurring R-()-lipoate but also S-()-lipoate, lipoate analogues, and
octanoate to the apoproteins, although S-lipoate and octanoate are used
at a 44 and 16% rate ofR-lipoate, respectively (5, 6). LplAhas amolecular
mass of 37,795Da, consisting of 337 amino acids excluding the initiating
methionine residue, which is cleaved off during the biosynthesis (5).
Strains with lplA null mutations have severe defects in the incorpora-
tion of exogenously supplied lipoic acid and lipoic acid analogues into
apoproteins (5, 7).
In E. coli, there is another enzyme, LipB, responsible for the covalent
attachment of lipoic acid. LipB transfers lipoic acid/octanoic acid endo-
genously synthesized on the acyl carrier protein by the function of LipA
to the lipoate-dependent enzymes (7–9). LipB consists of 213 amino
acids, whose amino acid sequence shares only 12.7% identitywith that of
LplA (Fig. 1).On the other hand, the amino acid sequence of LplA shows
31 and 35% identity with those of human and bovine lipoyltransferase,
the mammalian LplA homologues, respectively (Fig. 1). However, the
mammalian lipoyltransferases have no ability to activate lipoate to
lipoyl-AMP and catalyze only the second half-reaction (10, 11). Strong
homology in the N-terminal half region suggests that the regionmay be
responsible for the second transfer reaction, whereas some residue(s) in
the C-terminal region of the E. coli enzyme may be essential for the
lipoate-activating reaction, which are lacking in the mammalian
sequences (10).
To elucidate the structure-function relationship, we determined the
crystal structure of LplA.We present here the structures of two forms of
LplA: native and lipoate complex forms. LplA consists of two domains,
the N-terminal and the C-terminal domains with a substrate binding
pocket at the interface between these two domains. Lipoic acid is bound
on the N-terminal domain side in the pocket through hydrophobic
interactions. This is the first report on the crystal structure of the
enzymes responsible for the lipoic acid metabolism.
* This work was supported in part by grants-in-aid from the Ministry of Education, Cul-
ture, Sports, Science, and Technology of Japan. The costs of publication of this article
were defrayed in part by the payment of page charges. This articlemust therefore be
hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
Theatomic coordinates and structure factors (codes 1X2Gand1X2H)havebeendeposited in
theProteinDataBank, ResearchCollaboratory for Structural Bioinformatics, RutgersUni-
versity, New Brunswick, NJ (http://www.rcsb.org/).
1 To whom correspondence should be addressed. Tel.: 81-88-633-9254; Fax: 81-88-633-
7428; E-mail: fujiwara@ier.tokushima-u.ac.jp.
2 The abbreviations used are: LplA, lipoate-protein ligase A; Se-LplA, selenomethionine-
substituted LplA; APMSF, (p-amidinophenyl) methanesulfonyl fluoride hydrochlo-
ride; DTT, dithiothreitol; r.m.s., root mean square.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 280, NO. 39, pp. 33645–33651, September 30, 2005
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
SEPTEMBER 30, 2005•VOLUME 280•NUMBER 39 JOURNAL OF BIOLOGICAL CHEMISTRY 33645
 at O
SA
K
A
 U
N
IV
ERSITY
 on N
ovem
ber 10, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
EXPERIMENTAL PROCEDURES
Construction of the Expression Vector Containing lplA Gene—DNA
manipulations were accomplished by the standard techniques (12). The
gene encoding LplA was amplified by a PCR from the E. coli BL21(DE3)
gene using a pair of oligonucleotides, 5-AGGGTACCATATGTCCA-
CATTACGCCTGCTCA-3 (NdeI (underlined), Met (boldface letters),
and nucleotides 86–104 (5)) and 5-AGGGATCCTACCTTACAGC-
CCCCGCCAT-3 (BamHI (underlined), Stop codon (boldface letters),
and nucleotides 1096–1079) designed on the basis of the lplA sequence.
The PCR product was inserted into the pET-3a expression vector (13).
The construct pET-LPLA was verified by DNA sequencing and trans-
formed into E. coli expression strain BL21(DE3)pLysS or
B834(DE3)pLysS to obtain native LplA or selenomethionine-substi-
tuted LplA (Se-LplA), respectively. Cells were cultured inM9ZB (13) or
Doublie´ and Carter medium supplemented with selenomethionine (30
mg/liter) (14) containing 25 g/ml ampicillin, 25 g/ml chloramphen-
icol, and 25 M isopropyl--D-thiogalactopyranoside at 30 °C for 22 h.
The bacterial cells were harvested by centrifugation.
Purification of the Recombinant LplA—Both LplA and Se-LplA were
purified to homogeneity by the following method. E. coli cells were sus-
pended in 40 mM Tris-HCl, pH 7. 5, 1 mM dithiothreitol (DTT), 40 M
(p-amidinophenyl) methanesulfonyl fluoride hydrochloride (APMSF),
and 10 g/ml leupeptin and lysed by sonication. The cell extract was
obtained by centrifugation at 105,000  g for 1 h and applied onto a
hydroxylapatite column (3  6 cm) equilibrated with 3 mM potassium
phosphate buffer, pH 7. 4. LplA was eluted with 4 mM potassium phos-
phate buffer, pH 7. 4, containing 0.5 mM DTT and 10 M APMSF and
further purified by a HiPrep 16/10 DEAE column (Amersham Bio-
sciences) equilibratedwith 20mMTris-HCl, pH 7. 5, containing 0. 5mM
DTT and 10 M APMSF. Proteins retained were eluted with a linear
gradient of 0–0.2 M NaCl in the equilibration buffer. LplA fraction
eluted at about 0. 1 M NaCl was concentrated with Centriplus YM-30
(Millipore Corp.) and applied onto a Superdex 200 pg 16/60 column
(Amersham Biosciences). The column was developed with 40 mMTris-
HCl, pH 7.5, containing 1 mM DTT, 0. 5 mM EDTA, 10 M APMSF, 5%
glycerol, 0.16 M NaCl. In the Superdex gel, the protein behaved as a
monomer.
Mutation of LplA—Mutations of S72A and R140A were introduced
using an In-Fusion PCR Cloning kit (BD Biosciences Clontech). For the
S72Amutation, PCRs were carried out employing pET-LPLA as a tem-
plate and primer 1 (5-AAGGAGATATACATATGTCCACAT-
TACGC-3 (pET-3a sequence (underlined) and then nucleotides 83–97
(5))) and primer 2 (5- GCCACCGGCACTGCGCCGCGCCAG-3
(nucleotides 307–278; modified bases are shown in boldface letters)) to
amplify the N-terminal half and primer 3 (5- CGCAGTGCCGGTG-
GCGGCGCGGT-3 (nucleotides 293–326)) and primer 4 (5-GTTAG-
CAGCCGGATCCTAC-3 (pET-3a sequence (underlined) and nucleo-
tides 1099–1096)) to amplify the C-terminal half. For the R140A
mutation, primer 1 and primer 5 (5-GGTTTCGGCATAGGC-
CGAGCCTGAGA-3 (nucleotides 511–486)) and primer 6 (5-GC-
CTATGCCGAAACCAAAGATCGCGG-3 (nucleotides 497–522))
and primer 4 were employed to amplify the N-terminal and C-terminal
half, respectively. After the recombination reaction with pET-3a
digested with NdeI and BamHI and the pair of the PCR products, the
resultant plasmid was transformed into E. coli BL21(DE3)pLysS. The
mutant LplAs were expressed and purified up to the DEAE-Sepharose
FIGURE 1. The amino acid sequence alignment of E. coli and putative S. pneumoniae (S. p.) LplA, the human lipoyltransferase (LT), and E. coli LipB. The residues conserved
among four proteins, those between E. coli LplA and S. pneumonia LplA or human LT, and LipB are shown on a blue, yellow, and green background, respectively. The secondary
structure elements of E. coli the LplA are assigned using the programDSSP (37).-Helices, 310-helices, and-strands are representedwithmagenta rectangles, orange rectangles, and
blue arrows, respectively. Amino acid numbering of E. coli LplA starts at the serine residue following the initiation methionine (5), that of S. pneumoniae LplA starts at the initiation
methionine residue (30), that of human LT starts at the N-terminal amino acid of the mature proteins (11), and that of LipB starts at the methionine residue added to the N-terminal
extended active LipB (9). The sequence alignment was carried out using ClustalW (38).
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step as described above. The purified wild-type andmutant LplAs in the
DEAE-Sepharose fractions were apparently homogeneous on SDS-
polyacrylamide gel electrophoresis and used for the steady state kinetic
analysis.
Assay of LplA—The activity of LplA was determined in the reaction
mixture of 50l containing 40mMpotassium phosphate buffer, pH 7. 0,
0.3 mg/ml bovine serum albumin, 0. 5 mM DTT, 3 M E. coli apoH-
protein as a lipoate acceptor, 30M R-()-lipoic acid, 2 mMATP, 2 mM
MgCl2, and appropriate amounts of wild-type or mutant LplA. After
preincubation for 90 s, the reaction was started by the addition of ATP
or lipoic acid and carried out for 5 min at 37 °C. The reaction was
terminated by heating the mixture at 95 °C for 70 s. The amount of
lipoylated H-protein in themixture was determined by the glycine-CO2
exchange activity using E. coli P-protein as described previously (4).
Apparent Km values of wild-type and mutant LplA for lipoic acid, ATP,
and apoH-protein were determined by varying the concentration of one
substratewith a constant concentration of the other two substrates. The
constant concentrations are the same as those in the standard assay
mixture described above. The concentrations of varied substrates were
1.25–80M for lipoic acid, 2.5–1000M forATP, and 0.188–4.5M for
apoH-protein. R-()-lipoate was generously provided by ASTA-Med-
ica (Frankfurt amMain, Germany). The recombinant E. coli apoH-pro-
tein was prepared as described for the preparation of holoH-protein
except that E. coli cells were grown in the medium without an addition
of lipoic acid (15).
Crystallization—Crystallization was carried out at 20 °C by the hang-
ing drop-vapor diffusion method using a protein solution dialyzed
against 5 mM HEPES-Na, pH 7.5, and 3 mM DTT. Se-LplA was crystal-
lized in a droplet containing a 1:1 ratio of protein solution at 3 mg/ml
and reservoir solutions of 12.5–14.5% ethylene glycol and 21% glycerol.
Crystals of Se-LplAlipoate complex was grown with a modified protein
solution at 5 mg/ml and a reservoir solution containing 3 mM R-()-
lipoate.
DataCollection—All X-ray data were collected at 100K on the beam-
line BL44XU at SPring-8 (Hyogo, Japan). The structure of Se-LplA was
solved using Se-SAD methods (16). Before data collection, wavelength
was calibrated by fluorescence scan of the Se-LplA crystal, and a wave-
length was selected for data collection corresponding to the white line
(peak,  0.9796 Å). Data were collected in a 180° sweep in 1° oscilla-
tion steps, using an imaging plate detector, and then integrated and
scaled with the programs MOSFLM (17) and SCALA (18). The data
collection for crystal of Se-LplAlipoate complex was carried out with a
wavelength of 0.9215 Å sweeping 90° in 1° oscillation steps. The crystal
containing lipoate was very weak against radiation damage; therefore,
two data sets had to be merged to get enough data for the structure
determination. Each data set was indexed and integrated with DENZO
and then scaled and merged with SCALEPACK (19). The LplA crystals
belong to space group C2221 with unit cell dimensions of a  81.6 Å,
b  112.1 Å, and c  289.2 Å for Se-LplA crystal used for structure
determination.
Structure Determination—All of the 15 expected selenium sites (for
three monomers containing 5 Se-Met residues/asymmetric unit) were
found using the heavy atom search program in CNS (20), and the initial
phases were calculated with SHARP (21). 2.8 Å resolution maps calcu-
lated after density modification by SOLOMON (22) implemented in
SHARP was used for determination of molecule mask and noncrystal-
lographic symmetry operators for further density improvement. Solvent
flattening, histogram mapping, and noncrystallographic symmetry
averaging were applied for phase improvement using DM (23), and the
resulting map was used for model building. The structure of
Se-LplAlipoate was solved by the molecular replacement method with
MOLREP (24) in theCCP4 suite (25) using Se-LplA structure as a search
model.
Model Building and Refinement—Model building and refinement for
all structures were performed using the programs O (26) and REF-
MAC5 (27) in CCP4 suite (25), respectively. Refinement for Se-LplA
wasmonitoredwith theRfree value calculated for a randomly selected 5%
of reflections in the data set. The Rfree values of Se-LplAlipoate were
calculated with the reflections, which were used for calculation of Rfree
values of Se-LplA. To build an Se-LplA structure, the quality of the
initial experimental electron density map and known selenium sites
allowed unambiguous tracing for the protein backbone and side chains.
The protein model of Se-LplA was refined against the 43.6–2.4 Å reso-
lution data set. The geometry library of lipoic acid was made using a
monomer library sketcher in CCP4 suite (25). The Ramachandran plot
was defined by PROCHECK (28).
RESULTS ANDDISCUSSION
Structure Determination—Crystallization of E. coli LplA was men-
tioned about 10 years ago (6). The structure had never been determined,
presumably because of the difficulty to obtain crystals suitable for the
structural analysis. Hexagonal shape crystals of Se-LplA (0. 06 0. 08
0. 1 mm) without substrate were obtained in 2 weeks by the hanging
drop-vapor diffusion method, employing ethylene glycol as a precipi-
TABLE ONE
Data collection and refinement statistics
Se-LplA Se-LplA Se-LplAlipoatecomplex
Data collection
Space group C2221 C2221 C2221
Cell dimensions (Å)
a 81.6 82.0 83.2
b 112.1 112.8 111.6
c 289.2 289.4 289.6
Wavelength (Å) 0.9796 0.9000 0.9215
Resolution range (Å) 33.9–2.8 43.6–2.4 66.7–2.9
(3.0–2.8)a (2.5–2.4) (3.0–2.9)
No. of unique reflections 33,110 52,725 29,247
Completeness (%) 100 (99.9) 99.4 (99.7) 97.4 (99.0)
I/ (I) 6.1 (1.0) 18.0 (2.9) 15.6 (3.8)
Rmerge (%)b 9.9 (66.6) 5.9 (29.7) 12.0 (42.1)
Structure refinement
Resolution (Å) 43.62.4 66.72.9
No. of reflections 49,805 27,666
Rc/Rfreed (%) 17.1/23.3 18.6/27.1
r.m.s. deviation
Bond length (Å) 0.021 0.020
Bond angle (degrees) 1.830 1.976
Atoms per asymmetric unit
Protein 7895 7891
Lipoic acid 24
Water 530 22
Ramachandran plot
Most favored (%) 89.9 85.7
Additional allowed (%) 9.7 14.0
Generously allowed (%) 0.3 0.2
a The numbers in parentheses represent statistics in the highest resolution shell.
b Rmerge  jI(h)  I(h)j/jI(h), where I(h) is the mean intensity of sym-
metry-equivalent reflections.
c R  Fo  Fc/Fo, where Fo and Fc are the observed and calculated structure
factors for data used for refinement, respectively.
d Rfree  Fo  Fc/Fo for 5% of the data not used at any stage of structural
refinement.
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tant. The space group of the crystal was determined to be C2221. The
phase problem for LplA was solved by the SAD method, and the initial
model could be built into the electron density. The final structure was
refined using a 2.4Å resolution data set, with cell dimensions of a 82.0
Å, b  112.8 Å, c  289.4 Å. Results of the X-ray data collection and
refinement statistics are summarized in TABLE ONE. Although cell
dimensions were slightly changed among the crystals used, all crystals,
the native and complex crystals, kept the same space group and similar
cell dimension with a slight lack of isomorphism. There are three LplA
molecules (MolA, MolB, and MolC) in the asymmetric unit (Fig. 2A).
All residues (1–337) of the MolC could be assigned in the electron
density; however, the density corresponding to residues 177–182 and
176–182 aremissing inMolA andMolB, respectively. The final R factor
for the reflection data used for refinement (working set) is 17.1%, and
the Rfree value is 23.3%. Superpositions of C positions of MolA and
MolB, MolA and MolC, and MolB and MolC give root mean square
(r.m.s.) deviations of 0.57, 0.70, and 0.86 Å, respectively. Despite rela-
tively large r.m.s. deviations among the crystallographically independ-
ent molecules, they keep almost identical structures except for some
loop regions (Fig. 2B). MolA and MolC are related by the noncrystallo-
graphic 2-fold symmetry, and they form a dimer structure. The same
relationship is also found between MolB and the adjacent MolB related
by a crystallographic 2-fold symmetry (MolB). The contact surface area
ofMolA andMolC is 4507Å2 (13.6%of the sumof the surface area of the
monomers), and that ofMolB andMolB is 4196Å2 (12.9% of the sumof
surface area of the monomers) (29). Although the crystal structure of
LplA shows dimer formation in a crystal, the gel filtration experiment
shows that LplA is amonomer in solution. The dimer structure seems to
be the result by the crystal packing.
Overall Structure of LplAMolecule—Fig. 2C shows aC trace of LplA
(MolC). LplA consists of a large N-terminal domain (residues 1–244)
and a small C-terminal domain (residues 253–337) connected by a sin-
gle stretch of the polypeptide (residues 245–252). The N-terminal
domain comprises two -sheets, a large mixed -sheet consisting of six
strands (1, 2, 6, 8, 9, and 10) and a small mixed -sheet consisting
of three strands (3–5), with seven -helices (1–7) and a 310-helix
(3101) surrounding the -sheets. The C-terminal domain consists of
three -helices (8–10), two 310-helices (3102 and 3103), and a -sheet
comprising three strands (12–14). An open and solvent-exposed cleft
is formed between the two domains. Fig. 1 shows the location of the
secondary structure elements for the E. coli LplA, together with the
amino acid sequence alignment of E. coli and putative Streptococcus
pneumoniae LplA (30), human lipoyltransferase, and E. coli LipB.
Amino acid residues well conserved among four proteins and between
LplA and lipoyltransferase line inside of the cleft (on1,4 to5,9, and
10). These results suggest that the cleft is a substrate-binding pocket.
The structure of LplA is similar to that of the putative lipoate-protein
ligase from S. pneumoniae (Protein Data Bank accession code 1VQZ),
which gives a Z-score of 29.8 for an alignment of 303/326 residue with
an r.m.s. deviation of 3. 1 Å and 31% sequence identity by the DALI
FIGURE 2. Themolecular architecture of LplA. A,
ribbon representation of three LplA molecules
(MolA, MolB, and MolC) seen in the asymmetric
unit in theC2221 spacegroup.MolA (red) andMolC
(blue) are relatedby thenoncrystallographic 2-fold
symmetry. MolB (green) and MolB (cyan), which
belongs to an adjacent asymmetric unit, are
related by the crystallographic 2-fold symmetry.
Orange ellipses show positions of the 2-fold axis. B,
superposition of three crystallographically inde-
pendent molecules (MolA (red), MolB (green), and
MolC (blue)) in the asymmetric unit drawn by tube
model of C trace. Although slight structural
changes are found among thesemolecules (MolA-
MolB, r.m.s. deviation 0.57 Å; MolA-MolC, r.m.s.
deviation 0.70 Å; MolB-MolC, r.m.s. deviation 0.86
Å), overall fold shows almost identical structures
except for some loop regions.N and C indicate the
NandCtermini, respectively.C, thestereoviewofthe
nativeSe-LplAstructure (MolC).Theprotein is shown
asa ribbon representationwithbluecoloringat theN
terminus along the rainbow colors to red at theC ter-
minus. The lipoic acidmolecule of MolA of the com-
plex structure was superimposed and shown in a
ball-and-stickmode. The figurewas generatedusing
MOLSCRIPT (39) and RASTER3D (40).
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program (31). The high structural similarity confirmed by superposition
of the-carbon traces of the putative protein and LplA suggests that the
putative protein is a homologue of the E. coli lipoate-protein ligase A.
The Lipoic Acid Binding Site—Because lipoic acid is a labile com-
pound, LplA crystals complexed with R-()-lipoic acid were obtained
by seeding small crystals of the Se-LplAlipoate complex into a droplet
to accelerate the crystallization. Crystals suitable for analysis were
obtained within 3 days after setting the droplet. The lipoic acid-bound
form was determined at 66.7–2.9 Å resolution. Weak but significant
electron density corresponding to lipoic acid was found in MolA and
MolB (Fig. 3,A andB). Positions of the lipoic acid inMolA andMolB are
slightly different. This may be caused by weak interactions between
LplA and lipoic acid or insufficient information from low resolution
data. Lipoic acid is located in a hydrophobic core generated by Leu-17,
Phe-24, Phe-147, Ala-138, and aliphatic parts of Glu-21 and Ser-72 side
chains. Hydrophobic interactions are formed between these residues
and the dithiolane ring and the hydrophobic tail of lipoic acid. Leu-17,
Ser-72, and Ala-138 are well conserved among LplAs and lipoyltrans-
ferase (Fig. 1). The electron density for the carboxyl group is weak rel-
ative to that for the hydrophobic moiety. In MolA, the carboxyl group
makes a hydrogen bond with the side chain of Ser-72, whereas inMolB,
the carboxyl group hydrogen bonds to the side chain of Arg-140 (Fig. 3,
C and D). Although the actual binding mode may change somewhat
when higher resolution x-ray data are eventually obtained, this complex
provides insights into lipoic acid binding to the LplAmolecule. Because
van der Waals interactions are neither strong nor specific, and a weak
hydrogen bond occurs only at the carboxyl group, it may permit LplA to
bind not only R-()-lipoic acid but also S-()-lipoic acid, lipoic acid
analogues, and octanoic acid. The bindingmodewell explains why LplA
activates these carboxylic acids and transfers them to apoproteins (6, 7,
32). The reaction ratesmay be influenced by the slight differences in the
van der Waals interactions between LplA and these substrates.
Functional and Structural Similarities to Other Proteins—A system-
atic analysis using the DALI program (31) identified a number of pro-
teins/domains with significant structural similarities to LplA. The clos-
est of them other than the LplA homologue is BirA, biotin holoenzyme
FIGURE 3. The lipoic acid binding site. Stereo
views of the lipoic acid binding site inMolA (A) and
MolB (B). The electron density of lipoic acid calcu-
lated with coefficients of the form A-weighted
2mFoDFc is plotted at the 1.0  level (light blue),
where Fo is the native structure factor amplitude,
and Fc is the calculated structure factor amplitude
(25). Peptide chains of LplA are shown in coil rep-
resentation (dark green). Amino acid side chains
(dark green) and lipoic acid (orange) are shown in
ball-and-stick mode. The figures were produced
with BOBSCRIPT (41) and RASTER3D (40). C and D,
schematic diagram showing the lipoic acid and
LplA interactions in MolA and MolB, respectively.
Lipoic acid andall of the LplA residues that interact
with lipoic acid are shown in a flattened represen-
tation. Lipoic acid atoms with short red lines repre-
sent hydrophobic interactions pointing toward
the LplA residues also outlined with red lines. The
greendashed lines showpotential hydrogenbonds
between atoms with distance (in Å). This figure
was generated with LIGPLOT (42).
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synthetase/bio repressor from E. coli (Protein Data Bank accession
codes 1BIA and 1BIB) (33), which gives a Z-score of 9.4 for an alignment
of 139/292 residues with an r.m.s. deviation of 3.5 Å and 12% sequence
identity. BirA consists of three domains and functions as a repressor of
the biotin biosynthetic operon and as an enzyme that catalyzes the
activation and transfer of biotin to a specific lysine residue on the biotin-
dependent carboxylases. The reactionmechanism is remarkably similar
to that of LplA. The central domain contributes to the catalysis. Fig. 4
shows a superposition of LplA (residues 1–337) onto BirA (the central
and C-terminal domains, residues 68–317) according to the rotation
and translation matrices provided by DALI. Several -helices (1, 4,
and 5) and -strands (1, 2, 6, 7, 9, and 10) of LplA are well
superimposed on the corresponding secondary structure elements of
BirA. In both enzymes, lipoic acid and biotin interact with -strands in
the N-terminal domain and the central domain, respectively, and the
substrates are situated in the similar position in the respective enzymes.
Functional and structural similarities of these enzymes suggest that evo-
lutionarily they are closely related, although they share only 12% amino
acid sequence identity. The absence of a DNA binding domain in the
LplA structure may be related to the finding that LplA metabolizes
lipoic acid that is exogenously supplied rather than that synthesized
endogenously in E. coli (5, 7).
Mechanistic Implication—Ser-72 and Arg-140 residues, respectively,
were substituted byAla to analyze the contribution of the residues to the
lipoic acid binding (Fig. 3). Steady state kinetic studies were carried out
by varying the concentration of one substrate and keeping the concen-
tration of the other two substrates constant. Apparent kinetic constants
are shown in TABLE TWO.
Whereas the S72A mutation results in an about 2-fold increase in
Km(app) for lipoic acid, Km(app) for ATP is greatly increased by the muta-
tion, indicating the reduced binding affinity for ATP. This result sug-
gests that the hydrogen bond between lipoic acid and Ser-72may not be
so critical to fix lipoic acid at the position determined by the crystal
structural analysis. However, the fixation of the carboxyl group to
Ser-72 is required for the initiation of the lipoate activation reaction
with ATP, or ATP may interact directly with Ser-72.
The R140Amutation results in reducedVmax(app) values, although the
values differ depending on the varied substrate because of the usage of
the limited concentration of apoH-protein. Km(app) for lipoic acid is
rather decreased.On the other hand,Km(app) for apoH-protein increases
by 1 order of magnitude, indicating a reduction of the binding affinity
for apoH-protein. In the protein lipoylation reaction, the presence of the
Glu residue at the three residuesN-terminal side from the Lys residue to
be lipoylated in the lipoate acceptor protein is essential (34, 35). There-
fore, Arg-140 in LplAmaymake a salt bridge with the Glu residue in the
apoH-protein in the second transfer reaction (Reaction 2). These results
of the kinetic analyses support the lipoic acid binding mode shown in
Fig. 3 (i.e. lipoic acid is bound at the position by the hydrophobic inter-
actions, and the weak hydrogen bond between the carboxyl group and
the Ser-72 or the Arg-140 residue is enough to accommodate lipoic
acid).
We attempted to obtain a crystal of the LplAATP complex by soak-
ing the native crystal with Mg-ATP and by co-crystallization in the
presence of Mg-ATP. However, X-ray analysis of the crystals did not
show electron density for ATP clear enough to determine the ATP
binding site. The first step of the reaction catalyzed by LplA is thought to
TABLE TWO
Kinetic constants for wild-type andmutant LplAs
Varied substrate Km(app)a Vmax(app)a,b
M nmol/min/mg protein
Wild-type
R-()-lipoic acid 4.5 219
ATP 15.8 133
ApoH-protein 1.2 258
S72A
R-()-lipoic acid 8.9 178
ATP 295 160
ApoH-protein 1.1 212
R140A
R-()-lipoic acid 0.55 6.0
ATP 13.7 8.4
ApoH-protein 15.5 28.1
a The values are presented as a mean of two or three separate experiments with an
S.E. of less than 10%.
b Since an inhibition of the glycine-CO2 exchange reaction was observed by the use
of over 5 M apoH-protein in the assay of LplA, a fixed concentration of 3 M
apoH-protein was used. Consequently, Vmax(app) values were underestimated
when the concentrations of ATP and lipoic acid were varied.
FIGURE 4. Stereo view of the superimposed structure of LplA and BirA. -Carbon
traces of LplA (green, MolA, residues 1–337) and BirA (blue, residues 68–317) are super-
imposedaccording to thematricespresentedbyDALI. The crystallographically observed
lipoic acid (green) and biotin (blue) are shown in a space-filling representation.N, Central,
and C indicate the N-terminal, central, and C-terminal domains of the respective colored
protein. This figure was generated using MOLSCRIPT (39) and RASTER3D (40).
FIGURE 5. The hydrogen bond network around
Arg-70. Dashed lines show potential hydrogen
bonds between atomswith distances (in Å), which
are the averaged values of three crystallographi-
cally independent molecules. This figure was gen-
erated with MOLSCRIPT (39) and RASTER3D (40).
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be the nucleophilic attack of the carboxyl oxygen of lipoic acid on the
-phosphorus atom of ATP followed by the release of the pyrophos-
phate and the formation of a lipoyl-AMP intermediate by analogy to the
reaction catalyzed by histidyl-tRNA synthetase (36). The activated car-
bon atom of the lipoyl-AMP intermediate is then attacked by the non-
protonated -amino group of the lysine residue of an apoprotein to be
lipoylated, producing AMP and the lipoylated protein. To initiate the
first reaction, ATP should be anchored near the lipoic acid in LplA, and
especially the distance between the -phosphorus atom of ATP and the
carboxyl oxygen atom of lipoic acid should be less than 3 Å.
LplA has a characteristic sequence motif RRSSGGG between posi-
tions 69 and 75, which is highly conserved among the proteins listed in
Fig. 1. Themotif is situated on the loop following the4-strand (Fig. 2C)
close to the bound lipoic acid. In the native LplA structure, the side
chain of Arg-70 forms a hydrogen bond network with the main-chain
carbonyl groups of Gly-73 and Gly-75 and the side chain of Ser-72,
stabilizing the loop structure (Fig. 5). The motif can provide positive
charges and a space large enough to accommodate ATP. Therefore, the
motif is presumed to be involved in the binding of ATP or the adenylate
moiety of the lipoyl-AMP intermediate. Indeed, the mutation of Ser-72
affects the binding affinity for ATP (TABLE TWO). An R72G point
mutation in the human lipoyltransferase has been found in a hypergly-
cinemia patient, but nomutation has been found in the four proteins, P-,
T-, L-, andH-protein, constituting the human glycine cleavage system.3
The Arg-72 in the human lipoyltransferase corresponds to Arg-69 in
E. coli LplA. The mutation may cause the reduction of the lipoylation
level of H-protein of the glycine cleavage system, resulting in a decrease
in the activity of the glycine cleavage system. The expression of the
recombinant R72G mutant in E. coli failed presumably because of the
instability of the mutant protein.4 These findings also suggest that the
motif plays an important role for the binding of the substrate or the
stabilization of the three-dimensional structure.
Conclusions—The present study presents the LplA structure and its
substrate binding site for the first time. LplA consists of a large N-ter-
minal domain and a small C-terminal domain, comprising a substrate
binding pocket at the interface of the two domains. Lipoic acid is bound
to the N-terminal domain via hydrophobic interactions and a weak
hydrogen bond to Ser-72 or Arg-140 in the pocket. The result well
explains the reason why LplA utilizes lipoate analogues and octanoic
acid in addition to the natural substrate, R-()-lipoate. The large sol-
vent-exposed active site cleft is favorable to allow docking of the lipoate
acceptor protein to initiate the second transfer reaction. In an effort to
more fully define the active site geometry and to understand the reac-
tion mechanism of LplA, co-crystallization studies of LplA with ATP
and lipoyl-AMP are in progress.
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